Association among tenascin-C and NT-proBNP levels and arrhythmia prevalence in heart failure


Creative Commons License

Ozmen C., DENİZ A., DEVECİ O. S., ÇAĞLIYAN Ç. E., ÇELİK A. İ., Yildiz I., ...More

CLINICAL AND INVESTIGATIVE MEDICINE, vol.40, no.6, 2017 (SCI-Expanded) identifier identifier identifier

Abstract

Purpose: Tenascin-C (TN-C) and amino-terminal fragment of the B-type natriuretic
peptide (NT-proBNP) are the important predictors in prognosis of heart failure (HF).
The aim of this study was to analyze the relationship of TN-C and NT-proBNP levels
with the frequency and severity of ventricular arrhythmia.
Materials and Methods: Our study included 107 HF patients with EF < 45%. According
to Holter analysis, the patients were divided into two groups as malignant arrhythmia
group (n=29) with Lown Class 4a and 4b arrhythmia and benign arrhythmia
group(n=78) with Lown Class 0-3b arrhythmia. The groups were compared with respect
to levels of TN-C and NT-proBNP. The relationship of TN-C and NT-proBNP levels
with frequency of ventricular premature beat (VPB) was also analyzed.
Findings: NT-proBNP (5042.1±1626 versus 1417.1±1711.6 pg/ml) and TN-C
(1089±348.6 versus 758.5±423.9 ng/ml) levels were significantly higher in the malignant
arrhythmia group than that of the benign arrhythmia group (p<0.001). A significantly
strong positive correlation (r=0.741, p<0.001) was found between the NT-proBNP levels
and VPB numbers of the patients, whereas a significantly weak positive correlation was
detected between the TN-C levels and VPB numbers of the patients (r=0.347, p<0.001).
Conclusion: This study has shown that NT-proBNP and TN-C levels increase in the HF
patients with malignant arrhythmia. In the HF patients; the frequency of ventricular
arrhythmias also increases as NT-proBNP and TN-C levels increase. However, in this
study, the old NT-pro BNP seems better than the TN-C.